» Articles » PMID: 22185979

Modelling Hepatitis C Transmission over a Social Network of Injecting Drug Users

Overview
Journal J Theor Biol
Publisher Elsevier
Specialty Biology
Date 2011 Dec 22
PMID 22185979
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis C virus (HCV) is a blood-borne virus that disproportionately affects people who inject drugs (PWIDs). Based on extensive interview and blood test data from a longitudinal study in Melbourne, Australia, we describe an individual-based transmission model for HCV spread amongst PWID. We use this model to simulate the transmission of HCV on an empirical social network of PWID. A feature of our model is that sources of infection can be both network neighbours and non-neighbours via "importing". Data-driven estimates of sharing frequency and rate of importing are provided. Compared to an appropriately calibrated fully connected network, the empirical network provides some protective effect on the time to primary infection. We also illustrate heterogeneities in incidence rate of infection, both across and within node degrees (i.e., number of network partners). We explore the reduced risk of infection from spontaneously clearing cutpoint nodes whose infection status oscillates, both in theory and in simulation. Further, we show our model-based estimate of per-event transmission probability largely agrees with previous estimates at the lower end of the range 1-3% commonly cited.

Citing Articles

Agent based modelling of blood borne viruses: a scoping review.

Ale S, Hunter E, Kelleher J BMC Infect Dis. 2024; 24(1):1411.

PMID: 39695997 PMC: 11653803. DOI: 10.1186/s12879-024-10271-w.


Achieving Hepatitis C Micro-Elimination in Chinese Injecting Drug Users: A Dynamic Network Modeling Study.

Chen Y, Bao Y, Yan M, Jin H, Yao K, Zhang C Infect Dis Ther. 2024; 14(1):181-197.

PMID: 39663286 PMC: 11782747. DOI: 10.1007/s40121-024-01084-0.


Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis.

Grantz K, Cepeda J, Astemborski J, Kirk G, Thomas D, Mehta S J Viral Hepat. 2024; 32(4):e13999.

PMID: 39234877 PMC: 11880348. DOI: 10.1111/jvh.13999.


Predictors of Significant Liver Fibrosis in People with Chronic Hepatitis C Who Inject Drugs in the Czech Republic.

Frankova S, Uzlova N, Merta D, Pitova V, Sperl J Life (Basel). 2023; 13(4).

PMID: 37109461 PMC: 10144836. DOI: 10.3390/life13040932.


Multilevel network interventions: Goals, actions, and outcomes.

Robins G, Lusher D, Broccatelli C, Bright D, Gallagher C, Karkavandi M Soc Networks. 2022; 72:108-120.

PMID: 36188126 PMC: 9504355. DOI: 10.1016/j.socnet.2022.09.005.